XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
7 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 10. FAIR VALUE MEASUREMENTS


The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.


The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:


  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.


      December 31, 
   Level  2020 
Assets:       
Cash and marketable securities held in Trust Account  1  $319,577,125 
         
Liabilities:        
Warrant Liability – Public Warrants  1  $87,210,789 
Warrant Liability – Private Placement Warrants  3  $60,391,892 

The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations.


Initial Measurement


The Company established the initial fair value for the Warrants on August 20, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of common stock and one-half of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of common shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to common shares subject to possible redemption, and common shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.


The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement:


Input  August 20,
2020
(Initial Measurement)
 
Risk-free interest rate   0.4%
Expected term (years)   1 
Expected volatility   20.0%
Exercise price  $11.50 
Fair value of Units  $10.60 

On August 20, 2020, the Private Placement Warrants and Public Warrants were determined to be $1.38 and $1.33 per warrant for aggregate values of $10.7 million and $20.0 million, respectively.


Subsequent Measurement


The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market.


As of December 31, 2020, the aggregate values of the Private Placement Warrants and Public Warrants were $60.4 million and $87.2 million, respectively.


The following table presents the changes in the fair value of warrant liabilities:


   Private
Placement
   Public   Warrant
Liabilities
 
Fair value –  $   $   $ 
Initial measurement on August 20, 2020 (IPO)   10,695,000    19,950,000    30,645,000 
Measurement on August 27, 2020 (Over-Allotment)   536,915    1,293,654    1,830,569 
Change in valuation inputs or other assumptions   49,159,977    65,967,135    115,127,112 
Fair value as of December 31, 2020  $60,391,892   $87,210,789   $147,602,681 

Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $39,445,000 during the period from October 14, 2020 through December 31, 2020.


Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.


The fair value of the Private Placement Warrants was estimated at December 31, 2020 to be $7.42 and at September 30, 2020 to be $1.41 using the modified Black-Scholes option pricing model and the following assumptions:


   December 31,
2021
   September 30,
2020
 
Expected volatility   25.0%   25.0%
Risk-free interest rate   0.09%   0.11%
Expected term (years)   5    5 
Fair value per share of common stock  $17.78   $9.31